EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, StemRIM's enterprise value is 円19,338 Mil.
StemRIM's Revenue for the trailing twelve months (TTM) ended in Jan. 2024 was 円2,350 Mil. Therefore, StemRIM's EV-to-Revenue for today is 8.23.
The historical rank and industry rank for StemRIM's EV-to-Revenue or its related term are showing as below:
TSE:4599'
s EV-to-Revenue Range Over the Past 10 Years
Min: 7.21 Med: 20.05 Max: 3181.5
Current: 8.23
During the past 7 years, the highest EV-to-Revenue of StemRIM was 3181.50. The lowest was 7.21. And the median was 20.05.
TSE:4599's EV-to-Revenue is ranked worse than 50.1% of 1042
companies
in the Biotechnology industry
Industry Median: 8.215
vs TSE:4599: 8.23
As of today (2024-05-22), StemRIM's stock price is 円460.00.
StemRIM's Revenue per Share for the trailing twelve months (TTM) ended in Jan. 2024 was 円38.75. Therefore, StemRIM's PS Ratio for today is 11.87.
StemRIM EV-to-Revenue Historical Data
The historical data trend for StemRIM's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, StemRIM's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
StemRIM's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, StemRIM's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where StemRIM's EV-to-Revenue falls into.
StemRIM's current Enterprise Value is 円19,338 Mil.
StemRIM's Revenue for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円2,350 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
StemRIM's share price for today is 円460.00.
StemRIM's Revenue per Share for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円38.75.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
StemRIM EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of StemRIM's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
StemRIM Inc is a biotechnology company engaged in developing regeneration-guided medicines. The business activity of the group includes research, development, manufacture, and sales of pharmaceuticals and medical devices and products such as gene therapy that activate stem cells existing in the body and induce regeneration of damaged tissue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:4599 has been successfully added to your 